Lung Cancer News and Research

Latest Lung Cancer News and Research

Radiation therapy can be used to treat patients with life-threatening heart rhythm

Radiation therapy often is used to treat cancer patients. Now, doctors at Washington University School of Medicine in St. Louis have shown that radiation therapy - aimed directly at the heart - can be used to treat patients with a life-threatening heart rhythm.

14 Dec 2017

Targeted lung cancer treatments may benefit smokers and non-smokers alike

Smokers are less likely than non-smokers to have lung cancers caused by targetable genetic changes. But a study published this week in the journal Clinical Cancer Research shows that when they do, smokers benefit just as much as non-smokers from targeted treatments.

13 Dec 2017

Study finds rural-urban disparities in prevalence of dementia and cognitive impairment among seniors

Americans who live in urban areas tend to be healthier than individuals living in rural settings. While this healthcare disparity has been examined for more than a decade, researchers present the first nationally representative study to find that dementia and cognitive impairment have consistently been more prevalent among rural-dwelling seniors than urban dwelling seniors.

12 Dec 2017

New first line combination therapy shows promising results in patients with advanced NSCLC

A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.

7 Dec 2017

Immune-boosting drug combination may hold promise for treating ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.

5 Dec 2017

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.

30 Nov 2017

New software could make real-time DNA-authentication a reality

In the science-fiction movie Gattaca, visitors only clear security if a blood test and readout of their genetic profile matches the sample on file. Now, cheap DNA sequencers and custom software could make real-time DNA-authentication a reality.

30 Nov 2017

'Aggressive' surgery for early stage lung cancer provides better outcomes

Patients with early stage lung cancer live longer when they receive a lobectomy- the most common type of operation for the disease- rather than a less extensive operation or radiation treatment, according to a study published online today in The Annals of Thoracic Surgery.

30 Nov 2017

Study: Fewer new cases of lung cancer found in communities with strong smoke-free laws

A recent study by University of Kentucky BREATHE researchers shows that fewer new cases of lung cancer were found in communities with strong smoke-free workplace laws.

29 Nov 2017

Tobacco companies finally own up to cigarette smoking risks

It has been a decade since federal courts have found tobacco companies to be deceiving the general public by hiding the exact level of risk associated with cigarette smoking. Now finally the tobacco companies have agreed to own up the risks and air a set of advertisements on television and newspapers to correct the statements they have been making until now.

27 Nov 2017

Researchers question exclusion of people with prior cancer history from clinical trials

A quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer – often preventing them from participating in clinical trials, researchers from UT Southwestern's Simmons Cancer Center have found.

22 Nov 2017

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim and the German Center for Lung Research found after examining more than 500 patients.

22 Nov 2017

KAIST researchers identify principles of gene network for colon tumorigenesis

The principles of the gene network for colon tumorigenesis have been identified by a KAIST research team. The principles will be used to find the molecular target for effective anti-cancer drugs in the future. Further, this research gained attention for using a systems biology approach, which is an integrated research area of IT and BT.

20 Nov 2017

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 Congress, sumultaneously published in The New England Journal of Medicine.

20 Nov 2017

ATS debuts new video to highlight dangers of flavored tobacco

Educating the public about the dangers of tobacco addiction has long been a priority for the American Thoracic Society, which provides scientifically-supported arguments to counter Big Tobacco's marketing and lobbying efforts.

16 Nov 2017

Changes in multiple different genes drive world's most deadly forms of lung cancer

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant "driver" mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world's most deadly forms of lung cancer is driven by changes in multiple different genes, which appear to work together to drive cancer progression and to allow tumors to evade targeted therapy.

15 Nov 2017

Diet, smoking and alcohol main causes of death in OECD countries

The “Health at a Glance” report 2017 shows that over 10 million deaths have been recorded in the OECD countries in 2015. Thus the number of deaths on an average in these countries is 793 per 100,000 population.

13 Nov 2017

Elevated levels of chronic stress hormones may promote EGFR inhibitor resistance in NSCLC patients

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center.

9 Nov 2017

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

9 Nov 2017

Lung Cancer News and Research

Latest Lung Cancer News and Research

Radiation therapy can be used to treat patients with life-threatening heart rhythm

Targeted lung cancer treatments may benefit smokers and non-smokers alike

Study finds rural-urban disparities in prevalence of dementia and cognitive impairment among seniors

New first line combination therapy shows promising results in patients with advanced NSCLC

Immune-boosting drug combination may hold promise for treating ovarian cancer

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

New software could make real-time DNA-authentication a reality

'Aggressive' surgery for early stage lung cancer provides better outcomes

Study: Fewer new cases of lung cancer found in communities with strong smoke-free laws

Tobacco companies finally own up to cigarette smoking risks

Researchers question exclusion of people with prior cancer history from clinical trials

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

KAIST researchers identify principles of gene network for colon tumorigenesis

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

ATS debuts new video to highlight dangers of flavored tobacco

Changes in multiple different genes drive world's most deadly forms of lung cancer

Diet, smoking and alcohol main causes of death in OECD countries

Elevated levels of chronic stress hormones may promote EGFR inhibitor resistance in NSCLC patients

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in